IRONWOOD PHARMACEUTICALS, INC. Increase Decrease In Operating Lease Liability
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Increase Decrease In Operating Lease Liability of -$1.26 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-06
- IRONWOOD PHARMACEUTICALS, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$635.00K.
- IRONWOOD PHARMACEUTICALS, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$621.00K.
- IRONWOOD PHARMACEUTICALS, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$612.00K.
- IRONWOOD PHARMACEUTICALS, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$603.00K.
- IRONWOOD PHARMACEUTICALS, INC. increase decrease in operating lease liability for fiscal 2025 was -$2.37M.
- IRONWOOD PHARMACEUTICALS, INC. increase decrease in operating lease liability for fiscal 2024 was -$2.18M.
- IRONWOOD PHARMACEUTICALS, INC. increase decrease in operating lease liability for fiscal 2023 was -$2.00M.
- IRONWOOD PHARMACEUTICALS, INC. increase decrease in operating lease liability for fiscal 2022 was -$1.95M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$635.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.26M 10-Q · filed 2026-08-06 | -$1.87M derived: sum of 3 quarters · filed 2026-08-06 | -$2.47M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$621.00K 10-Q · filed 2026-05-07 | -$1.23M derived: sum of 2 quarters · filed 2026-05-07 | -$1.84M derived: sum of 3 quarters · filed 2026-05-07 | -$2.42M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$612.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.22M derived: sum of 2 quarters · filed 2026-02-26 | -$1.80M derived: sum of 3 quarters · filed 2026-08-06 | -$2.37M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$603.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$1.19M derived: sum of 2 quarters · filed 2026-08-06 | -$1.76M 10-Q · filed 2025-11-10 | -$2.32M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$584.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.16M 10-Q · filed 2026-08-06 | -$1.72M derived: sum of 3 quarters · filed 2026-08-06 | -$2.27M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$572.00K 10-Q · filed 2026-05-07 | -$1.13M derived: sum of 2 quarters · filed 2026-05-07 | -$1.69M derived: sum of 3 quarters · filed 2026-05-07 | -$2.23M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$562.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.12M derived: sum of 2 quarters · filed 2026-02-26 | -$1.65M derived: sum of 3 quarters · filed 2026-02-26 | -$2.18M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$554.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$1.09M derived: sum of 2 quarters · filed 2025-11-10 | -$1.61M 10-Q · filed 2025-11-10 | -$2.13M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$537.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$1.06M 10-Q · filed 2025-08-11 | -$1.58M derived: sum of 3 quarters · filed 2025-08-11 | -$2.08M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | -$523.00K 10-Q · filed 2025-05-12 | -$1.04M derived: sum of 2 quarters · filed 2025-05-12 | -$1.55M derived: sum of 3 quarters · filed 2025-05-12 | -$2.04M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$516.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$1.02M derived: sum of 2 quarters · filed 2025-03-31 | -$1.52M derived: sum of 3 quarters · filed 2025-03-31 | -$2.00M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$509.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.00M derived: sum of 2 quarters · filed 2024-11-07 | -$1.48M 10-Q · filed 2024-11-07 | -$1.95M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-06-30 | -$491.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$970.00K 10-Q · filed 2024-08-08 | -$1.44M derived: sum of 3 quarters · filed 2025-03-31 | -$1.94M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-03-31 | -$479.00K 10-Q · filed 2024-05-09 | -$952.00K derived: sum of 2 quarters · filed 2025-03-31 | -$1.45M derived: sum of 3 quarters · filed 2025-03-31 | -$1.94M derived: sum of 4 quarters · filed 2025-03-31 |
| 2022-12-31 | -$473.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$969.00K derived: sum of 2 quarters · filed 2025-03-31 | -$1.46M derived: sum of 3 quarters · filed 2025-03-31 | -$1.95M 10-K · filed 2025-03-31 |
| 2022-09-30 | -$496.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$991.00K derived: sum of 2 quarters · filed 2023-11-09 | -$1.47M 10-Q · filed 2023-11-09 | -$1.95M derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-06-30 | -$495.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$978.00K 10-Q · filed 2023-08-09 | -$1.45M derived: sum of 3 quarters · filed 2024-02-16 | -$1.92M derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-03-31 | -$483.00K 10-Q · filed 2023-05-04 | -$959.00K derived: sum of 2 quarters · filed 2024-02-16 | -$1.43M derived: sum of 3 quarters · filed 2024-02-16 | -$1.88M derived: sum of 4 quarters · filed 2024-02-16 |
| 2021-12-31 | -$476.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | -$944.00K derived: sum of 2 quarters · filed 2024-02-16 | -$1.40M derived: sum of 3 quarters · filed 2024-02-16 | -$1.83M 10-K · filed 2024-02-16 |
| 2021-09-30 | -$468.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$919.00K derived: sum of 2 quarters · filed 2022-11-03 | -$1.36M 10-Q · filed 2022-11-03 | -$1.79M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | -$451.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$891.00K 10-Q · filed 2022-08-04 | -$1.32M derived: sum of 3 quarters · filed 2023-02-16 | -$1.27M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | -$440.00K 10-Q · filed 2022-05-05 | -$873.00K derived: sum of 2 quarters · filed 2023-02-16 | -$815.00K derived: sum of 3 quarters · filed 2023-02-16 | |
| 2020-12-31 | -$433.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | -$375.00K derived: sum of 2 quarters · filed 2023-02-16 | $218.00K 10-K · filed 2023-02-16 | |
| 2020-09-30 | $58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $651.00K 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $593.00K 10-Q · filed 2021-08-05 | |||
| 2019-12-31 | -$12.05M 10-K · filed 2022-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |